drugset / Trial / NCT01818739

Lymph Node Mapping in Patients With Endometrial Cancer

NCT01818739

NaSingle-groupOpen-labelDiagnostic

Summary

This clinical trial studies lymph node mapping in patients with endometrial cancer. Lymph node mapping may allow for limited removal of lymph nodes in as part of endometrial cancer staging and treatment.

Timeline

Start
2013-03
Primary completion
2016-11-16
Completion
2017-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject indocyanine green solution Diagnostic / imaging agent
Subject isosulfan blue Diagnostic / imaging agent

Indications